Veterinary Medicine Market to Grow at 4.6% CAGR by 2030 with Advancing the Development of Innovative Veterinary Products

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

Veterinary medicine market

The demand for veterinary medicine is increasing due to the increasing acceptance of veterinary medicine around the world

Veterinary medicine is referred to as any product used to treat various diseases in animals. Veterinary medicine includes, for example, drugs such as anti-infectives and parasiticides. “

– Allied market research

PORTLAND, OR, UNITED STATES, Oct 6, 2021 / – The increase in pet ownership, the increase in livestock around the world, and the increase in animal health spending are fueling growth in the global veterinary medicine market. In addition, the increase in the prevalence of various diseases in animals is driving market growth. On the other hand, strict regulatory approvals related to veterinary drugs and vaccines, as well as a lack of veterinary infrastructure facilities in underdeveloped countries, inhibit growth to a certain extent. However, increasing animal health awareness is expected to create several opportunities in the industry.

Veterinary Medicine Market by Product (Drugs, Vaccines, and Medical Feed Additives), Route of Administration (oral route, parenteral route, and topical route), Animal Type (pets and farm animals), and Distribution Channel (Veterinary Clinics, Pharmacies, and Retail Veterinary Pharmacies): Global Opportunity Analysis and Industry Forecast, 2020-2027 “According to the report, the global veterinary medicine market was valued at $ 22.97 billion in 2019 and is projected to reach $ 29.69 billion by 2027, a CAGR of 4.6% from 2020 to 2027.

Get Sample PDF of Report @

Effects of Covid-19

– Veterinary drug production was not impacted during Covid-19 as most regions have veterinary drugs as an essential service.

– The Indian dairy industry has promoted the use of “Pashu Ayurveda” or ethno-veterinary medicine to curb animal diseases and control the likelihood of pathogens passing through them to humans.

– However, the interruptions in the supply chain were a major problem of raw material scarcity. In contrast, the government has relaxed certain restrictions in several regions in order to maintain economic benefits.

The drug segment is set to lead by 2027 –

Based on species, the pharmaceuticals segment contributed more than half of global sales in the veterinary market in 2019 and is expected to dominate through the end of 2027. This is due to the prevalence of parasites in both domestic animals and farm animals. However, the vaccine segment would have the fastest CAGR of 5.7% during the study period. This is due to the increase in the prevalence of various infectious diseases in pets and farm animals.

The parental route segment to maintain the lion’s share

Based on the route of administration, the parenteral route segment accounted for more than half of the global veterinary market share in 2019 and is expected to maintain its top status through 2027. The same segment is also expected to have the fastest CAGR of 5.2%. throughout the forecast period. The parenteral route of administration results in greater drug efficacy associated with the use of the parenteral route, higher bioavailability, and avoidance of first pass metabolism, which in turn drives segment growth.

North America remains lucrative in terms of sales

Geographically, North America had the largest share in 2019, holding more than two-fifths of the global veterinary medicine market. This is due to the ready availability of veterinary medicines, the rise in pet ownership, and increasing awareness of the importance of vaccination in both farm and domestic animals. On the other hand, Asia Pacific would also grow at the fastest CAGR of 6.3% through 2027. A growing awareness of the use of veterinary drugs to treat diseases in animals in this region is driving the growth of the market.

For purchase inquiries at:

Key player in the industry

Key market players include Zoetis, Inc., Merck & Co., Inc. (Intervet International BV), Elanco Animal Health, Dechra Pharmaceuticals PLC, Ceva Santé Animale, Virbac., Vetoquinol SA, Boehringer Ingelheim International GmbH., ADM Animal Nutrition and Evonik Industries AG.

Trend reports in the healthcare industry:

Global Male Hypogonadism Market Research Report 2030

Global Hypodermic Needles Market Research Report 2030

Avenue Basic Plan | Library access | 1 year subscription |

Sign up for an Avenue subscription to access 12,000+ company profiles and 2,000+ niche market research reports for $ 699 per month per seat. The customer must purchase at least 2 seats for one year.

Avenue Library Subscription | Request a 14-day free trial before purchasing:

More information:

We have also published some syndicated market research in a similar area that may be of interest to you. Below is the report title for your reference considering the impact of Covid-19 on this market

about us

Allied Market Research (AMR) is a full-service market research and management consulting arm of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides unmatched quality of “Market Research Reports” and “Business Intelligence Solutions” to global corporations as well as medium and small businesses. AMR has a focused perspective to provide business insights and advice to its clients to make strategic business decisions and achieve sustainable growth in their respective market area.

We have professional business relationships with various companies and this helps us unearth market data which will help us create accurate research data tables and confirm the highest accuracy of our market forecasts. Pawan Kumar, CEO of Allied Market Research, is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality data and help customers succeed in every possible way. All of the data presented in the reports we publish are extracted through primary interviews with top officials from leading companies in the domain in question. Our methodology for obtaining secondary data includes in-depth online and offline research and discussions with knowledgeable professionals and industry analysts.


David Correa
5933 NE Win Sivers Drive
# 205, Portland, OR 97220
United States
United States / Canada Toll Free: + 1-800-792-5285, + 1-503-894-6022, + 1-503-446-1141
United Kingdom: + 44-845-528-1300
Hong Kong: + 852-301-84916
India (Pune): + 91-20-66346060
Fax: +1(855)550-5975
David Correa
Allied Analytics LLP
email us here
+1 503-894-6022
Visit us on social media:

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:

You just read:

News provided by

October 06, 2021 at 7:08 pm GMT

EIN Presswire’s priority is source transparency. We don’t allow opaque clients, and our editors try to carefully weed out false and misleading content. If, as a user, you see something that we have overlooked, please make us aware of it. Your help is welcome. ONE Presswire, Everyone’s Internet News Presswire ™, seeks to define some of the boundaries that are appropriate in the world today. Please see our editorial guidelines for more information.

Submit your press release